A guide to common side effects and countermeasures of Dalilaysheng tablets

As a new drug for the treatment of insomnia, Daridorexant reduces the frequency of nighttime awakenings and prolongs sleep time by antagonizing OX1R and OX2R receptors, and is gradually being widely accepted in the European and American markets. However, although it is well tolerated, it may cause a range of mild to moderate side effects. Common clinical adverse reactions include dizziness, fatigue, daytime drowsiness, abnormal dreams, and decreased attention. Some patients may experience temporary memory blurring or decreased balance after long-term medication, especially the elderly who are more sensitive.

To better deal with these side effects, patients are first advised to strictly adhere to the medication time recommended by their doctors, usually within 30 minutes before going to bed and ensure a sufficient sleep window (not less than 7 hours). If significant daytime drowsiness occurs, consider adjusting dose or timing. In addition, avoid simultaneous use with other centrally depressant drugs (such as benzodiazepines, antihistamines) to avoid aggravating the sedative effect. Some users report enhanced dreams or anxiety and mood swings during the initial period of taking the drug. This is a normal transition period for the brain to adapt to orexin regulation, and it usually resolves within a few days.

It is worth noting that compared with traditional sleeping pills, Dalirasin has significantly lower addiction and drug resistance, but long-term continuous use without monitoring should still be avoided. In elderly patients or patients with liver and kidney dysfunction, the dose should be reduced as appropriate based on individual metabolic capacity to prevent adverse reactions from exacerbating. If adverse reactions occur that are persistent or affect the quality of life, you should seek medical treatment promptly to evaluate whether dressing change or combined intervention is needed. In short, although DaliRasen is a relatively safe new insomnia drug, scientific and reasonable use and adverse reaction management are still the key to ensuring its efficacy.

Reference materials:https://www.quviviq.com/